Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Cushing syndrome	5/155	5.687501326884178e-07	5.8012513534218614e-05	52.78666666666667	-159.46262935425068	ARMC5;CACNA1D;CTNNB1;CYP11B1;PRKACA
KEGG_2021_Human	Aldosterone synthesis and secretion	4/98	4.045325673294005e-06	0.00020631160933799424	56.5531914893617	-139.20816886591868	CACNA1D;CYP11B2;KCNJ5;PRKACA
KEGG_2021_Human	Renin secretion	3/69	6.857856994284154e-05	0.0017487535335424594	51.96103896103896	-96.07609532933417	CACNA1D;PRKACA;REN
KEGG_2021_Human	Cortisol synthesis and secretion	3/65	5.7322256772471596e-05	0.0017487535335424594	55.34101382488479	-100.98537671170521	CACNA1D;CYP11B1;PRKACA
KEGG_2021_Human	GnRH signaling pathway	3/93	0.00016720908178540931	0.0032212739648937484	37.99047619047619	-74.4091590745228	CACNA1D;GNRHR;PRKACA
KEGG_2021_Human	Circadian entrainment	3/97	0.00018948670381727933	0.0032212739648937484	36.35562310030395	-71.7056117119453	CACNA1D;KCNJ5;PRKACA
KEGG_2021_Human	Serotonergic synapse	3/113	0.00029777417443940563	0.00433899511325991	31.005194805194805	-62.561773808196286	CACNA1D;KCNJ5;PRKACA
KEGG_2021_Human	Dopaminergic synapse	3/132	0.000470602596573688	0.006000183106314522	26.375415282392026	-54.23696242085085	CACNA1D;KCNJ5;PRKACA
KEGG_2021_Human	Retrograde endocannabinoid signaling	3/148	0.0006580280370873506	0.007457651086989973	23.417733990147784	-48.687210890592894	CACNA1D;KCNJ5;PRKACA
KEGG_2021_Human	Oxytocin signaling pathway	3/154	0.0007390260491982426	0.007538065701822075	22.47019867549669	-46.86692877135684	CACNA1D;KCNJ5;PRKACA
KEGG_2021_Human	Ovarian steroidogenesis	2/51	0.0017026970091094645	0.01578864499356049	40.91326530612245	-49.32882798945731	LHCGR;PRKACA
KEGG_2021_Human	cAMP signaling pathway	3/216	0.001968898347391993	0.01673563595283194	15.804828973843058	-33.39161145354852	CACNA1D;LHCGR;PRKACA
KEGG_2021_Human	GnRH secretion	2/64	0.0026692305210442593	0.01815076754310096	32.28225806451613	-40.62246695267589	CACNA1D;KCNJ5
KEGG_2021_Human	Steroid hormone biosynthesis	2/61	0.0024277716033486584	0.01815076754310096	33.936440677966104	-42.34896129219215	CYP11B1;CYP11B2
KEGG_2021_Human	Calcium signaling pathway	3/240	0.002662203143410756	0.01815076754310096	14.160940325497288	-29.862034348996023	CACNA1D;LHCGR;PRKACA
KEGG_2021_Human	Amphetamine addiction	2/69	0.0030959091544989293	0.019736420859930673	29.854477611940297	-38.032897794694755	CACNA1D;PRKACA
KEGG_2021_Human	Arrhythmogenic right ventricular cardiomyopathy	2/77	0.0038409427449733026	0.023045656469839818	26.643333333333334	-34.49723066158141	CACNA1D;CTNNB1
KEGG_2021_Human	Insulin secretion	2/86	0.00476943508022695	0.027026798787952715	23.761904761904763	-31.205674037146366	CACNA1D;PRKACA
KEGG_2021_Human	GABAergic synapse	2/89	0.005099890907028776	0.02716239345833322	22.933908045977013	-30.23706529396038	CACNA1D;PRKACA
KEGG_2021_Human	Morphine addiction	2/91	0.005325959501633964	0.02716239345833322	22.412921348314608	-29.62208544121757	KCNJ5;PRKACA
KEGG_2021_Human	Dilated cardiomyopathy	2/96	0.005911165720442844	0.028711376356436672	21.20744680851064	-28.182173664612183	CACNA1D;PRKACA
KEGG_2021_Human	Melanogenesis	2/101	0.006524751197354676	0.030251119187735313	20.123737373737374	-26.866639949507174	CTNNB1;PRKACA
KEGG_2021_Human	Cholinergic synapse	2/113	0.008111349626545349	0.03506563487806238	17.92117117117117	-24.127023560492017	CACNA1D;PRKACA
KEGG_2021_Human	Glutamatergic synapse	2/114	0.008250737618367619	0.03506563487806238	17.758928571428573	-23.921532741216183	CACNA1D;PRKACA
KEGG_2021_Human	Thyroid hormone signaling pathway	2/121	0.009256905435456077	0.03631555209294307	16.699579831932773	-22.566638560549244	CTNNB1;PRKACA
KEGG_2021_Human	Growth hormone synthesis, secretion and action	2/119	0.008964014539605185	0.03631555209294307	16.98931623931624	-22.939511285821055	CACNA1D;PRKACA
KEGG_2021_Human	Vascular smooth muscle contraction	2/133	0.011103972768351109	0.04194834156932641	15.146946564885496	-20.537590301958808	CACNA1D;PRKACA
KEGG_2021_Human	Estrogen signaling pathway	2/137	0.011753397776716717	0.04281594904375375	14.690740740740742	-19.931093924152265	KCNJ5;PRKACA
KEGG_2021_Human	Adrenergic signaling in cardiomyocytes	2/150	0.0139780795801668	0.04916427990265564	13.378378378378379	-18.15870698745584	CACNA1D;PRKACA
KEGG_2021_Human	Wnt signaling pathway	2/166	0.01694985420863817	0.05762950430936978	12.048780487804878	-16.318740700598067	CTNNB1;PRKACA
KEGG_2021_Human	Tight junction	2/169	0.01753509480713479	0.05769611839766932	11.827844311377245	-16.008452091357693	CACNA1D;PRKACA
KEGG_2021_Human	Proteoglycans in cancer	2/205	0.025220492252545426	0.08039031905498854	9.685960591133005	-12.928804077098514	CTNNB1;PRKACA
KEGG_2021_Human	Renin-angiotensin system	1/23	0.028125816737661832	0.08693434264368202	40.63636363636363	-20.601670877696893	REN
KEGG_2021_Human	Human cytomegalovirus infection	2/225	0.029995320515188703	0.08998596154556611	8.794843049327355	-11.607417281005194	CTNNB1;PRKACA
KEGG_2021_Human	Chemical carcinogenesis	2/239	0.03354092254711208	0.09774783142301234	8.26054852320675	-10.803362590978235	CACNA1D;PRKACA
KEGG_2021_Human	Prion disease	2/273	0.04281158988095726	0.12129950466271223	7.192804428044281	-9.169844698845731	CACNA1D;PRKACA
KEGG_2021_Human	Thyroid cancer	1/37	0.04489527895199197	0.12376536359738327	24.790123456790123	-13.876145105511855	CTNNB1
KEGG_2021_Human	MAPK signaling pathway	2/294	0.04897898942595734	0.13146991898546442	6.657534246575342	-8.337786615237395	CACNA1D;PRKACA
KEGG_2021_Human	Vasopressin-regulated water reabsorption	1/44	0.053181957430960346	0.13909127328097323	20.73643410852713	-11.926003967456698	PRKACA
KEGG_2021_Human	Carbohydrate digestion and absorption	1/47	0.05671353920929476	0.14049182423703138	19.3768115942029	-11.24402387762608	CACNA1D
KEGG_2021_Human	Vibrio cholerae infection	1/50	0.060233261208856796	0.14049182423703138	18.183673469387756	-10.63265628196324	PRKACA
KEGG_2021_Human	Human papillomavirus infection	2/331	0.06060431633754296	0.14049182423703138	5.880699088145897	-7.115618067766183	CTNNB1;PRKACA
KEGG_2021_Human	Cocaine addiction	1/49	0.05906133610748362	0.14049182423703138	18.564814814814813	-10.829316375605623	PRKACA
KEGG_2021_Human	Type II diabetes mellitus	1/46	0.05553766478796506	0.14049182423703138	19.809876543209878	-11.46289716991079	CACNA1D
KEGG_2021_Human	Endocrine and other factor-regulated calcium reabsorption	1/53	0.06374115884515756	0.1416978963668893	17.128205128205128	-10.081098986019231	PRKACA
KEGG_2021_Human	Neuroactive ligand-receptor interaction	2/341	0.06390297287134222	0.1416978963668893	5.699852507374631	-6.82883638517627	GNRHR;LHCGR
KEGG_2021_Human	Regulation of lipolysis in adipocytes	1/55	0.06607320562588742	0.1428791933124145	16.48971193415638	-9.74227359341278	PRKACA
KEGG_2021_Human	Hedgehog signaling pathway	1/56	0.06723726744113623	0.1428791933124145	16.187878787878788	-9.580691348846925	PRKACA
KEGG_2021_Human	Endometrial cancer	1/58	0.06956147443988561	0.14480143658914962	15.61598440545809	-9.271975415581295	CTNNB1
KEGG_2021_Human	Alzheimer disease	2/369	0.07347088540357372	0.14988060622329039	5.2459128065395095	-6.1057863985118	CACNA1D;CTNNB1
KEGG_2021_Human	Basal cell carcinoma	1/63	0.0753492056247738	0.1506984112495476	14.347670250896057	-8.574814690072902	CTNNB1
KEGG_2021_Human	Long-term potentiation	1/67	0.07995603885498047	0.15683684544630785	13.47138047138047	-8.082458738692866	PRKACA
KEGG_2021_Human	Prolactin signaling pathway	1/70	0.08339759626885078	0.15969083103411266	12.880837359098228	-7.74542097629872	LHCGR
KEGG_2021_Human	Adherens junction	1/71	0.08454220466511847	0.15969083103411266	12.695238095238095	-7.638591016595616	CTNNB1
KEGG_2021_Human	Gastric acid secretion	1/76	0.09024597396088518	0.1635272630029559	11.841481481481482	-7.141387005986298	PRKACA
KEGG_2021_Human	Bacterial invasion of epithelial cells	1/77	0.09138288226635771	0.1635272630029559	11.68421052631579	-7.04872976578505	CTNNB1
KEGG_2021_Human	Thyroid hormone synthesis	1/75	0.0891077855134448	0.1635272630029559	12.003003003003004	-7.236197160831004	PRKACA
KEGG_2021_Human	Cardiac muscle contraction	1/87	0.10268183855515577	0.17169478372641425	10.31266149870801	-6.225752347944314	CACNA1D
KEGG_2021_Human	Bile secretion	1/90	0.10604677818396174	0.17169478372641425	9.961298377028713	-6.010407578745034	PRKACA
KEGG_2021_Human	Gap junction	1/88	0.10380474953181053	0.17169478372641425	10.192848020434228	-6.152535327455873	PRKACA
KEGG_2021_Human	Hypertrophic cardiomyopathy	1/90	0.10604677818396174	0.17169478372641425	9.961298377028713	-6.010407578745034	CACNA1D
KEGG_2021_Human	Taste transduction	1/86	0.10155766145487406	0.17169478372641425	10.435294117647059	-6.300464747037211	PRKACA
KEGG_2021_Human	Colorectal cancer	1/86	0.10155766145487406	0.17169478372641425	10.435294117647059	-6.300464747037211	CTNNB1
KEGG_2021_Human	Salivary secretion	1/93	0.1094003568916107	0.17397304783610223	9.632850241545894	-5.8073541800756905	PRKACA
KEGG_2021_Human	Amoebiasis	1/102	0.11939326812281527	0.17397304783610223	8.764576457645765	-5.262086311101535	PRKACA
KEGG_2021_Human	Longevity regulating pathway	1/102	0.11939326812281527	0.17397304783610223	8.764576457645765	-5.262086311101535	PRKACA
KEGG_2021_Human	Inflammatory mediator regulation of TRP channels	1/98	0.11496450084552494	0.17397304783610223	9.130584192439862	-5.49346810373269	PRKACA
KEGG_2021_Human	Prostate cancer	1/97	0.11385418156418702	0.17397304783610223	9.226851851851851	-5.553951626329874	CTNNB1
KEGG_2021_Human	Pathways of neurodegeneration	2/475	0.11356791602477233	0.17397304783610223	4.014270613107822	-4.131104230952899	CACNA1D;CTNNB1
KEGG_2021_Human	Progesterone-mediated oocyte maturation	1/100	0.11718138394436346	0.17397304783610223	8.94388327721661	-5.375723879218761	PRKACA
KEGG_2021_Human	Glucagon signaling pathway	1/107	0.1249011740201087	0.17694332986182065	8.345911949685535	-4.994589105830365	PRKACA
KEGG_2021_Human	Parathyroid hormone synthesis, secretion and action	1/106	0.12380207979004104	0.17694332986182065	8.426455026455027	-5.046288872333345	PRKACA
KEGG_2021_Human	Leukocyte transendothelial migration	1/114	0.13256015588280526	0.1852210397266594	7.822025565388397	-4.655477238055189	CTNNB1
KEGG_2021_Human	Pathways in cancer	2/531	0.13679480156092927	0.18855499674614576	3.5628544423440456	-3.410136075895621	CTNNB1;PRKACA
KEGG_2021_Human	Platelet activation	1/124	0.14339691916847833	0.19501981006913052	7.177055103884372	-4.231046804704064	PRKACA
KEGG_2021_Human	Relaxin signaling pathway	1/129	0.1487694756391342	0.1970712534440479	6.892361111111111	-4.041189892105298	PRKACA
KEGG_2021_Human	Oocyte meiosis	1/129	0.1487694756391342	0.1970712534440479	6.892361111111111	-4.041189892105298	PRKACA
KEGG_2021_Human	Autophagy	1/137	0.15730251033809037	0.2005607006810652	6.480392156862745	-3.763669230249352	PRKACA
KEGG_2021_Human	Apelin signaling pathway	1/137	0.15730251033809037	0.2005607006810652	6.480392156862745	-3.763669230249352	PRKACA
KEGG_2021_Human	Insulin signaling pathway	1/137	0.15730251033809037	0.2005607006810652	6.480392156862745	-3.763669230249352	PRKACA
KEGG_2021_Human	Fluid shear stress and atherosclerosis	1/139	0.15942370386618251	0.2007557752388965	6.384863123993559	-3.698840756963446	CTNNB1
KEGG_2021_Human	Signaling pathways regulating pluripotency of stem cells	1/143	0.163651680714637	0.20356672479137775	6.2018779342723	-3.57415842622014	CTNNB1
KEGG_2021_Human	Breast cancer	1/147	0.16786050842791683	0.20628640794756045	6.0289193302891935	-3.455697502915966	CTNNB1
KEGG_2021_Human	Gastric cancer	1/149	0.16995776547310146	0.20637728664590893	5.945945945945946	-3.3986573195730956	CTNNB1
KEGG_2021_Human	Cellular senescence	1/156	0.17726075583432344	0.21147126961191243	5.672401433691756	-3.209640069203435	CACNA1D
KEGG_2021_Human	Hepatitis C	1/157	0.17829930575122027	0.21147126961191243	5.635327635327635	-3.183908163692195	CTNNB1
KEGG_2021_Human	Hippo signaling pathway	1/163	0.1845058664849509	0.2163172227754597	5.422496570644719	-3.0356632226338247	CTNNB1
KEGG_2021_Human	cGMP-PKG signaling pathway	1/167	0.1886201000678787	0.2173467975680337	5.289156626506024	-2.942334294710352	CACNA1D
KEGG_2021_Human	Hepatocellular carcinoma	1/168	0.18964573513289215	0.2173467975680337	5.256819693945443	-2.919648521708157	CTNNB1
KEGG_2021_Human	Alcoholism	1/186	0.20790875456503763	0.23562992184037598	4.734534534534535	-2.5504914662503393	PRKACA
KEGG_2021_Human	Chemokine signaling pathway	1/192	0.21391358807496763	0.238270226829055	4.5823152995927865	-2.441961042053517	PRKACA
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	1/193	0.21491040066934372	0.238270226829055	4.55787037037037	-2.4244944960200487	CTNNB1
KEGG_2021_Human	Focal adhesion	1/201	0.22284403856827387	0.24138153918921004	4.371111111111111	-2.2907190203417165	CTNNB1
KEGG_2021_Human	Viral carcinogenesis	1/203	0.22481613944093093	0.24138153918921004	4.326732673267327	-2.2588473265567357	PRKACA
KEGG_2021_Human	Diabetic cardiomyopathy	1/203	0.22481613944093093	0.24138153918921004	4.326732673267327	-2.2588473265567357	REN
KEGG_2021_Human	Rap1 signaling pathway	1/210	0.23168307497366095	0.24616326715951475	4.178096757044125	-2.1518791496475385	CTNNB1
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	1/219	0.24043153000367978	0.25282490783892103	4.001019367991845	-2.0240281738454993	PRKACA
KEGG_2021_Human	Thermogenesis	1/232	0.25290994493508406	0.26057388266038967	3.7696007696007694	-1.8563524399324505	PRKACA
KEGG_2021_Human	Ras signaling pathway	1/232	0.25290994493508406	0.26057388266038967	3.7696007696007694	-1.8563524399324505	PRKACA
KEGG_2021_Human	Salmonella infection	1/249	0.2689494049142217	0.271612270309412	3.503584229390681	-1.6629804039719844	CTNNB1
KEGG_2021_Human	Parkinson disease	1/249	0.2689494049142217	0.271612270309412	3.503584229390681	-1.6629804039719844	PRKACA
KEGG_2021_Human	Olfactory transduction	1/440	0.4290230576444395	0.4290230576444395	1.9309035687167806	-0.5371969940112262	PRKACA
